B

Blue Jet Healthcare Ltd
NSE:BLUEJET

Watchlist Manager
Blue Jet Healthcare Ltd
NSE:BLUEJET
Watchlist
Price: 445.85 INR 0.54%
Market Cap: ₹77.3B

Blue Jet Healthcare Ltd
Gross Profit

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Blue Jet Healthcare Ltd
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
B
Blue Jet Healthcare Ltd
NSE:BLUEJET
Gross Profit
₹5.6B
CAGR 3-Years
13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Gross Profit
₹228.1B
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
10%
Cipla Ltd
NSE:CIPLA
Gross Profit
₹188.6B
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
8%
Divi's Laboratories Ltd
NSE:DIVISLAB
Gross Profit
₹63.6B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Lupin Ltd
NSE:LUPIN
Gross Profit
₹189.9B
CAGR 3-Years
26%
CAGR 5-Years
14%
CAGR 10-Years
8%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Gross Profit
₹96.4B
CAGR 3-Years
13%
CAGR 5-Years
11%
CAGR 10-Years
7%
No Stocks Found

Blue Jet Healthcare Ltd
Glance View

Market Cap
77.3B INR
Industry
N/A

Blue Jet Healthcare Ltd is a IN-based company operating in industry. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2023-11-01. Blue Jet Healthcare Limited is an India-based specialty pharmaceutical and healthcare ingredients and intermediates company. The Company’s operations are primarily organized in three product categories: contrast media intermediates, high-intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients (APIs). Contrast media are agents used in medical imaging to enhance the visibility of body tissues under X-rays, computed tomography (CT), magnetic resonance imaging (MRI) or ultrasound. Its high-intensity sweetener business includes development, manufacturing and marketing of saccharin and its salts. The Company’s contract development and manufacturing organization (CDMO) activity in the pharma intermediate and API business is primarily focused on collaborating with innovator pharmaceutical companies and multi-national generic pharmaceutical companies by providing them with pharma intermediates that serve as building blocks for APIs in chronic therapeutic areas.

BLUEJET Intrinsic Value
375.59 INR
Overvaluation 16%
Intrinsic Value
Price ₹445.85
B

See Also

What is Blue Jet Healthcare Ltd's Gross Profit?
Gross Profit
5.6B INR

Based on the financial report for Mar 31, 2025, Blue Jet Healthcare Ltd's Gross Profit amounts to 5.6B INR.

What is Blue Jet Healthcare Ltd's Gross Profit growth rate?
Gross Profit CAGR 3Y
13%

Over the last year, the Gross Profit growth was 44%. The average annual Gross Profit growth rates for Blue Jet Healthcare Ltd have been 13% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett